Google's AMIE hits The Lancet: 98 chats, zero halts
Google's conversational diagnostic AI AMIE has its first prospective real-clinic results in The Lancet: 98 completed chats, no safety stops, and a 90% differential hit rate.
7 verified stories covering AI Healthcare, product updates and industry developments.
Google's conversational diagnostic AI AMIE has its first prospective real-clinic results in The Lancet: 98 completed chats, no safety stops, and a 90% differential hit rate.
MIT researchers used a small-data AI algorithm to find a lipid nanoparticle formula that keeps an RNA vaccine stable for a year without refrigeration.
CMS's WISeR pilot lets AI contractors keep 25% of the Medicare spending they save by denying claims — one company has rejected over half of 6,000-plus applications across six states.
The FDA-approved study tests whether a high-bandwidth BCI and AI decoding can help restore speech for people who cannot speak.
YC-backed Stepful is using AI to shorten healthcare training programs as US hospitals struggle with a long-running staffing shortage.
Eli Lilly has signed a $2.75 billion agreement with Insilico Medicine to license a portfolio of AI-designed oral small-molecule drug candidates, marking a shift from using AI as a tool to purchasing AI-generated drugs themselves.
Eli Lilly has launched LillyPod, an in-house AI supercomputing cluster built with 1,016 NVIDIA Blackwell Ultra GPUs, and announced a joint $1 billion AI co-innovation lab with NVIDIA in San Francisco.